Novartis Purchase Of Chiron Puts Spotlight On Biologics
Chiron Corp. said Monday its board of directors has accepted a $5.1 billion takeover offer from Novartis, which already owns 42% of the beleaguered biotech company. Founded in 1981, Chiron is the third-oldest biotechnology company after industry leaders Amgen Inc. and Genentech Inc.
The acquisition will give...
To view the full article, register now.